Amandala Neuro Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

Amandala Neuro General Information

Description

Manufacturer of a clinical-stage biopharmaceutical platform intended to advance patient-centered psychedelic treatments for unmet mental health needs. The company offers development of a lead psychedelic asset and a care model aligned treatment approach, enabling patients with psychiatric disorders to access therapies that integrate within established psychiatric settings for improved treatment outcomes.

Contact Information

Formerly Known As
Eleusis Holdings Limited, Eleusis Interim Holdings Ltd
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 83 Cambridge Street, Pimlico
  • London SW1V 4PS
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 83 Cambridge Street, Pimlico
  • London SW1V 4PS
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amandala Neuro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition Completed Startup
1. Later Stage VC (Series B) 01-Jan-2021 Completed Startup
To view Amandala Neuro’s complete valuation and funding history, request access »

Amandala Neuro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amandala Neuro Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
FJ Labs Venture Capital Minority
Leafy Tunnel Venture Capital Minority
Lionheart Ventures Venture Capital Minority
Nex Gen VC Partners Venture Capital Minority
Second Bite Capital PE/Buyout Minority
To view Amandala Neuro’s complete investors history, request access »

Amandala Neuro FAQs

  • When was Amandala Neuro founded?

    Amandala Neuro was founded in 2017.

  • Where is Amandala Neuro headquartered?

    Amandala Neuro is headquartered in London, United Kingdom.

  • What is the size of Amandala Neuro?

    Amandala Neuro has 13 total employees.

  • What industry is Amandala Neuro in?

    Amandala Neuro’s primary industry is Drug Discovery.

  • Is Amandala Neuro a private or public company?

    Amandala Neuro is a Private company.

  • What is Amandala Neuro’s current revenue?

    The current revenue for Amandala Neuro is .

  • Who are Amandala Neuro’s investors?

    FJ Labs, Leafy Tunnel, Lionheart Ventures, Nex Gen VC Partners, and Second Bite Capital have invested in Amandala Neuro.

  • Who acquired Amandala Neuro?

    Amandala Neuro was acquired by Beckley Psytech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process